Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidating the Pivotal Neuroprotective Mechanisms and Therapeutic Variants of Erythropoietin in Neonatal Brain Injury. | Curr Top Med Chem | 2025 | 40325536 | PubTator, text mining | PubMed |
| Epo-calypse now. | Science | 2025 | 40273262 | PubTator, text mining | PubMed |
| Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. | Science | 2025 | 40273234 | PubTator, text mining | PubMed |
| Novel Mutations in Acute Erythroid Leukemia-A Case Report with Review of Literature. | Indian J Hematol Blood Transfus | 2025 | 40224680 | PubTator, text mining | PubMed |
| Evaluation of Erythropoietin and Erythropoietin Receptor Levels in Children with Autistic Spectrum Disorder: Cross-sectional Study. | Clin Psychopharmacol Neurosci | 2025 | 40223255 | PubTator, text mining | PubMed |
| H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia. | Hemasphere | 2025 | 40177616 | PubTator, text mining | PubMed |
| Baicalin-Geniposide combination modulates microglia polarization against chronic cerebral ischemia and concomitant kidney injury via the HIF-1α/EPO/NF-κB pathway. | J Neuroimmunol | 2025 | 40174480 | PubTator, text mining | PubMed |
| Clonal hematopoiesis landscape in frequent blood donors. | Blood | 2025 | 40067117 | PubTator, text mining | PubMed |
| Effect of oral fluid in urine samples on the analysis of selected erythropoietin receptor agonists and detection of saliva-specific markers for doping control purposes. | J Pharm Biomed Anal | 2025 | 40014892 | PubTator, text mining | PubMed |
| Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic. | Clin Lymphoma Myeloma Leuk | 2025 | 39947961 | PubTator, text mining | PubMed |
| Plasma Soluble Progenitor Cell Receptors as Biomarkers for Severe Anemia Among Malaria-Infected Pediatrics: A Prospective Study in Ghana. | Health Sci Rep | 2025 | 39931259 | PubTator, text mining | PubMed |
| B Lineage Acute Lymphoblastic Leukemia with concurrent IGH and EPOR rearrangements - An Entity with Dismal Outcome. | Indian J Hematol Blood Transfus | 2025 | 39917484 | PubTator, text mining | PubMed |
| Understanding the biochemistry of hormones - message in a bottle. | Essays Biochem | 2025 | 39916408 | PubTator, text mining | PubMed |
| Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction. | J Transl Med | 2025 | 39894850 | PubTator, text mining | PubMed |
| Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis. | Nat Commun | 2025 | 39880867 | PubTator, text mining | PubMed |
| Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia. | BMJ Case Rep | 2025 | 39842907 | PubTator, text mining | PubMed |
| Quantum Dot Erythropoietin Bioconjugates Enhance EPO-Receptor Clustering on Transfected Human Embryonic Kidney Cells. | Bioconjug Chem | 2025 | 39836713 | PubTator, text mining | PubMed |
| Prevalent integration of genomic repetitive and regulatory elements and donor sequences at CRISPR-Cas9-induced breaks. | Commun Biol | 2025 | 39833279 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Nobiletin: a potential erythropoietin receptor activator protects renal cells against hypoxia. | Apoptosis | 2025 | 39755823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers?page=6